leisure time -WSS

leisure time

author：fashion 2025-10-03 01:06:11 - browse：295

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Amazon expands telehealth clinic nationwide

WSS

NIH launches clinical trials and new research office for long Covid

Study identifies new proteins linked to dementia risk 25 years later

Tocagen's brain cancer gene therapy trial continues. Investors worry

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

National panel will explore requiring free Covid tests

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

leisure time

leisure time

leisure time

How to save PrEP access — and even expand it

Stanford president's case begs question: Who takes blame?

As demand for Covid shots wanes, Moderna seeks its next success

Tesla recalling nearly 16,000 of its 2021

Tori Bowie and the unacceptable rates of Black maternal death

Mega Millions pot grows to $1.25 billion after no winner

Psychedelics group wrestles with new pharma identity

5 important ways Henrietta Lacks changed medical science

How one medical school became remarkably diverse

Sage hopes for a blockbuster in antidepressant now before FDA

explore

EF3 tornado rips through North Carolina amid extreme weather nationwide

Winning ticket for $1 billion Powerball jackpot sold in California

Vir antibody drug aimed at influenza A fails in clinical trial

Sage hopes for a blockbuster in antidepressant now before FDA

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Vir antibody drug aimed at influenza A fails in clinical trial

hotspot

leisure time

entertainment

knowledge